Histologically, inhibition of AKT not only decreased the tumor features including hemorrhagic foci and neovascularization (Fig. S3B), but also reduced the levels of VEGF, b-FGF, and cyclin D1 (Fig. S3C). The gene discussed is FGF2; the disease is neoplasm.